Arbutus Biopharma Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan '25 Jan 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	566	495	329	303	389	221
Market Cap Growth	10.91%	50.38%	8.78%	-22.14%	76.02%	69.34%
Enterprise Value	501	396	223	157	411	258
Last Close Price	2.67	2.61	1.96	1.92	2.95	-
PS Ratio	52.10	100.41	23.11	9.34	47.89	43.60
PB Ratio	9.83	6.36	3.95	2.66	3.11	2.96
P/TBV Ratio	9.83	6.36	3.95	2.66	3.11	-
EV/Sales Ratio	46.70	80.32	15.69	4.85	50.59	51.00
Debt / Equity Ratio	0.06	0.06	0.08	0.09	0.11	0.22
Asset Turnover	0.12	0.05	0.11	0.20	0.06	0.06
Quick Ratio	18.31	8.03	5.71	4.51	13.92	13.06
Current Ratio	18.80	8.15	5.87	4.60	14.32	13.39
Return on Equity (ROE)	-45.88%	-68.76%	-59.99%	-45.35%	-56.19%	-72.97%
Return on Assets (ROA)	-16.46%	-31.68%	-28.70%	-19.76%	-26.22%	-29.51%
Return on Capital Employed (ROCE)	-33.90%	-60.30%	-64.00%	-38.90%	-37.10%	-44.90%
Earnings Yield	-5.56%	-11.28%	-17.38%	-19.05%	-14.49%	-21.15%
FCF Yield	-5.96%	-10.50%	-20.74%	-9.84%	-12.99%	-17.14%
Buyback Yield / Dilution	-5.88%	-11.84%	-9.95%	-42.07%	-40.10%	-32.83%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.